NanoViricides, Inc. announced today that the Company’s Form 10-SB, filed originally on November 14, 2006, has been declared effective by the Securities and Exchange Commission (“SEC”). NanoViricides now is subject to reporting and disclosure obligations under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) including the obligation to file with the SEC periodic reports, such as Annual Reports on Form 10-K (a detailed annual report of the Company’s operations), Quarterly Reports on Form 10-Q (a quarterly report of operations) and Current Reports on Form 8-K (a report of significant reportable events).
